PAPPAJOHN JOHN

SEC source: 0001213900-19-013143 · ownership.xml · derivative · entry 2

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires not disclosed

F2 · derivative.exercise_price: The reporting person received his shares of Series A Preferred Stock pursuant to an Exchange Agreement with MYnd and Telemynd. under which he exchanged previously held securities for shares of Series A Preferred Stock.

F2 · price: The reporting person received his shares of Series A Preferred Stock pursuant to an Exchange Agreement with MYnd and Telemynd. under which he exchanged previously held securities for shares of Series A Preferred Stock.

F3 · derivative.exercise_date: The shares of Series A Preferred Stock have no expiration date and are convertible at any time at the election of the Reporting Person without payment of further consideration.

F3 · derivative.expiration_date: The shares of Series A Preferred Stock have no expiration date and are convertible at any time at the election of the Reporting Person without payment of further consideration.

SEC source: 0001213900-19-013143 · ownership.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,132,925

F1 · shares: Telemynd, Inc. ("Telemynd") was formerly a wholly-owned subsidiary of MYnd Analytics, Inc. ("MYnd"). On July 15, 2019, pursuant to the Amended and Restated Separation and Distribution Agreement, dated as of March 27, 2019, between MYnd and Telemynd, the Reporting Person received a pro rata distribution of common stock of Telemynd.

F1 · price: Telemynd, Inc. ("Telemynd") was formerly a wholly-owned subsidiary of MYnd Analytics, Inc. ("MYnd"). On July 15, 2019, pursuant to the Amended and Restated Separation and Distribution Agreement, dated as of March 27, 2019, between MYnd and Telemynd, the Reporting Person received a pro rata distribution of common stock of Telemynd.

SEC source: 0001615774-19-008336 · s118516_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,117,925

F1 · balance_after: Does not include 15,000 restricted shares that are subject to vesting.

SEC source: 0001615774-19-004072 · s116731_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 917,925

F1 · balance_after: Does not include 15,000 restricted shares that are subject to vesting.

SEC source: 0000905718-19-000094 · ownership.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,781,204

SEC source: 0000905718-19-000055 · cancer_form4jan142019.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,781,204

SEC source: 0001615774-18-010691 · s113208_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 832,925

F1 · shares: The above restricted shares were granted under Mynd Analytics, Inc.'s (the "Company") Amended and Restated 2012 Omnibus Incentive Compensation Plan and vest quarterly.

SEC source: 0001615774-18-009968 · s112892_form4.xml · derivative · entry 2

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,135

Underlying: Common Stock · 135,135 shares

Expires 2023-09-23

F2 · price: Reporting Person purchased 135,135 units at a price of $1.85 per unit, with each unit consisting of: (i) one share of Common Stock and (ii) one Common Stock Purchase Warrant to purchase one share of Common Stock for $2.00 per share.

SEC source: 0001615774-18-009968 · s112892_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 802,925

F1 · security: 135,135 shares of Common Stock and Warrants to purchase 135,135 shares of Common Stock for $2.00 were purchased by the Reporting Person for an aggregate of $250,000 pursuant to a Subscription Agreement, dated September 21, 2018 (the "Subscription Agreement"), between the Issuer and the investors party thereto.

SEC source: 0001615774-18-008752 · s112368_form4a.xml · nonDerivative · entry 2

PAPPAJOHN JOHN · CIK 0000897464 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 667,790

SEC source: 0001615774-18-008752 · s112368_form4a.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 617,790

SEC source: 0001615774-18-008733 · s112361_form4.xml · nonDerivative · entry 2

PAPPAJOHN JOHN · CIK 0000897464 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 667,790

SEC source: 0001615774-18-008733 · s112361_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 617,790

SEC source: 0001615774-18-004580 · s110525_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 567,790

F1 · shares: On May 25, 2018, the Board of Directors (the "Board") of MYnd Analytics, Inc. granted the indicated number of restricted shares (the "Shares") in lieu of the remaining amount of the Reporting Person's Board fee for the 2017-2018 fiscal year. The Shares were issued pursuant to the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan.

SEC source: 0001615774-18-002319 · s109514_form4.xml · derivative · entry 4

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires not disclosed

F1 · derivative.exercise_price: 500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the "Subscription Agreement"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share.

F4 · derivative.exercise_price: Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation).

F4 · derivative.exercise_date: Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation).

F4 · derivative.expiration_date: Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation).

F3 · ownership.nature: Reporting Person beneficially owns 500,000 shares of Series a Preferred Stock and Warrants to purchase 500,000 shares of Common Stock that were purchased by his spouse, Mary Pappajohn. These shares of Series a Preferred Stock and Warrants were purchased pursuant to the Subscription Agreement, dated as of March 29, 2018. Mr. Pappajohn disclaims beneficial ownership of any shares of Series A Preferred Stock and Warrants held by Mrs. Pappajohn.

SEC source: 0001615774-18-002319 · s109514_form4.xml · derivative · entry 3

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires not disclosed

F1 · derivative.exercise_price: 500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the "Subscription Agreement"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share.

F4 · derivative.exercise_price: Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation).

F4 · derivative.exercise_date: Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation).

F4 · derivative.expiration_date: Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation).

SEC source: 0001615774-18-002319 · s109514_form4.xml · derivative · entry 2

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires not disclosed

F1 · derivative.exercise_price: 500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the "Subscription Agreement"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share.

F1 · shares: 500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the "Subscription Agreement"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share.

F2 · shares: Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock.

F2 · price: Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock.

F2 · derivative.exercise_date: Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock.

F2 · derivative.expiration_date: Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock.

F1 · derivative.underlying_shares: 500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the "Subscription Agreement"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share.

F2 · derivative.underlying_shares: Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock.

F3 · ownership.nature: Reporting Person beneficially owns 500,000 shares of Series a Preferred Stock and Warrants to purchase 500,000 shares of Common Stock that were purchased by his spouse, Mary Pappajohn. These shares of Series a Preferred Stock and Warrants were purchased pursuant to the Subscription Agreement, dated as of March 29, 2018. Mr. Pappajohn disclaims beneficial ownership of any shares of Series A Preferred Stock and Warrants held by Mrs. Pappajohn.

SEC source: 0001615774-18-002319 · s109514_form4.xml · derivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires not disclosed

F1 · derivative.exercise_price: 500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the "Subscription Agreement"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share.

F1 · shares: 500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the "Subscription Agreement"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share.

F2 · shares: Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock.

F2 · price: Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock.

F2 · derivative.exercise_date: Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock.

F2 · derivative.expiration_date: Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock.

F1 · derivative.underlying_shares: 500,000 shares of Series A Preferred Stock and Warrants to purchase 500,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $1,000,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the "Subscription Agreement"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share.

F2 · derivative.underlying_shares: Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 500,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock.

SEC source: 0001615774-18-000188 · s108669_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 563,290

SEC source: 0001349929-17-000096 · wf-form4_151302979599364.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,781,204

F1 · price: 1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.842 to $1.862, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001349929-17-000085 · wf-form4_150697866321552.xml · derivative · entry 2

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2027-09-28

F2 · derivative.exercise_date: The option vests in two equal installments on September 28, 2018 and September 28, 2019, respectively.

SEC source: 0001349929-17-000085 · wf-form4_150697866321552.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,631,204

F1 · shares: The restricted stock underlying the award vests in two equal installments on September 28, 2018 and September 28, 2019, respectively.

SEC source: 0001615774-17-005238 · s107565_form4.xml · derivative · entry 2

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-09-19

F1 · derivative.exercise_date: The option vests in four equal quarterly installments beginning on December 19, 2017.

SEC source: 0001615774-17-005238 · s107565_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 553,290

SEC source: 0001349929-17-000067 · wf-form4a_150308834343802.xml · nonDerivative · entry 2

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,628,704

F2 · date: The original Form 4, filed on August 18, 2017 is amended to correctly reflect the transaction date. No other changes have been made to the original Form 4.

F3 · price: 1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.30, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0001349929-17-000067 · wf-form4a_150308834343802.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,608,704

F1 · price: 1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.30, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001349929-17-000065 · wf-form4_150308754502820.xml · nonDerivative · entry 2

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,628,704

F2 · price: 1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.30, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0001349929-17-000065 · wf-form4_150308754502820.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,608,704

F1 · price: 1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.30, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001615774-17-004226 · s107135_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 541,290

SEC source: 0001615774-17-004052 · s107025_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 536,290

SEC source: 0001615774-17-003843 · s106916_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 531,290

SEC source: 0001615774-17-003801 · s106893_form4.xml · nonDerivative · entry 2

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 526,290

SEC source: 0001615774-17-003801 · s106893_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 521,290

SEC source: 0001615774-17-003722 · s106856_form4.xml · nonDerivative · entry 2

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 516,290

SEC source: 0001615774-17-003722 · s106856_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 511,290

SEC source: 0001349929-17-000055 · wf-form4_149729829786206.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,542,519

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.575 to $3.80, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001349929-17-000049 · wf-form4_149695411672230.xml · derivative · entry 2

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.0001 per share · 10,000 shares

Expires 2027-06-07

F2 · derivative.exercise_date: The option vests in two equal installments on June 7, 2018 and June 7, 2019, respectively.

SEC source: 0001349929-17-000049 · wf-form4_149695411672230.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,442,519

F1 · shares: The restricted stock underlying the award vests in two equal installments on June 7, 2018 and June 7, 2019, respectively.

SEC source: 0001349929-17-000035 · wf-form4_149505280305709.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,440,019

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.75 to $3.85, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001615774-17-001821 · s105933_form4.xml · nonDerivative · entry 11

PAPPAJOHN JOHN · CIK 0000897464 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 1,750,930

SEC source: 0001615774-17-001821 · s105933_form4.xml · nonDerivative · entry 10

PAPPAJOHN JOHN · CIK 0000897464 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 1,750,871

SEC source: 0001615774-17-001821 · s105933_form4.xml · nonDerivative · entry 9

PAPPAJOHN JOHN · CIK 0000897464 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 1,750,397

SEC source: 0001615774-17-001542 · s105823_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 506,290

SEC source: 0001615774-17-001821 · s105933_form4.xml · nonDerivative · entry 8

PAPPAJOHN JOHN · CIK 0000897464 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 1,738,272

SEC source: 0001615774-17-001821 · s105933_form4.xml · nonDerivative · entry 7

PAPPAJOHN JOHN · CIK 0000897464 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 1,735,086

SEC source: 0001615774-17-001821 · s105933_form4.xml · nonDerivative · entry 6

PAPPAJOHN JOHN · CIK 0000897464 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 1,730,786

SEC source: 0001615774-17-001186 · s105635_form4.xml · nonDerivative · entry 1

PAPPAJOHN JOHN · CIK 0000897464 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 496,412

F1 · kind: Purchased in a private placement of securities by the issuer.

SEC source: 0001615774-17-001821 · s105933_form4.xml · nonDerivative · entry 5

PAPPAJOHN JOHN · CIK 0000897464 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 1,710,709

SEC source: 0001615774-17-001821 · s105933_form4.xml · nonDerivative · entry 4

PAPPAJOHN JOHN · CIK 0000897464 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 1,709,309

SEC source: 0001615774-17-001821 · s105933_form4.xml · nonDerivative · entry 3

PAPPAJOHN JOHN · CIK 0000897464 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 1,708,609